ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Several factors influence the survival of CML‐CP patients, including clonal chromosomal abnormalities (CCA) in Philadelphia chromosome‐positive cells, BCR‐ABL1 kinase domain mutations, non‐ABL kinase dependencies, and multidrug resistance polymorphisms.